Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study.
Lancet Haematol
; 10(9): e735-e746, 2023 Sep.
Article
em En
| MEDLINE
| ID: mdl-37517413
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Mielofibrose Primária
/
Inibidores de Janus Quinases
/
Anemia
Tipo de estudo:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
Limite:
Adolescent
/
Adult
/
Humans
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article